Search research articles
Contact Us
Filters
Showing results (151-160 of 210) with videos related to
Page
of 21
Sort By:
Cell Death and Differentiation
|
October 14, 2017
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux
Roberta Ranieri, Elena Ciaglia, Giuseppina Amodio, et al.
Journal of Leukocyte Biology
|
July 13, 2013
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation
Elena Ciaglia, Simona Pisanti, Paola Picardi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 20, 2012
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
Chiara Laezza, Alba D'Alessandro, Simona Paladino, et al.
Molecular Pharmacology
|
September 20, 2008
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase
Iolanda Esposito, Maria Chiara Proto, Patrizia Gazzerro, et al.
Frontiers in Oncology
|
January 30, 2020
N<sup>6</sup>-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression
Giovanna Navarra, Cristina Pagano, Roberto Pacelli, et al.
Genes & Nutrition
|
March 26, 2011
Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells
Maria Notarnicola, Simona Pisanti, Valeria Tutino, et al.
International Journal of Cancer
|
November 5, 2016
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor
Elena Ciaglia, Mario Abate, Chiara Laezza, et al.
International Journal of Molecular Sciences
|
April 16, 2020
Multifaceted Role of PRDM Proteins in Human Cancer
Amelia Casamassimi, Monica Rienzo, Erika Di Zazzo, et al.
International Journal of Molecular Sciences
|
March 11, 2023
Impacts of Environmental Pollution on Brain Tumorigenesis
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
FEBS Open Bio
|
March 22, 2024
N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity
Cristina Pagano, Laura Coppola, Giovanna Navarra, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 210) with videos related to
Sort By:
Page
of 21
Cell Death and Differentiation
|
October 14, 2017
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux
Roberta Ranieri, Elena Ciaglia, Giuseppina Amodio, et al.
Journal of Leukocyte Biology
|
July 13, 2013
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation
Elena Ciaglia, Simona Pisanti, Paola Picardi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 20, 2012
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
Chiara Laezza, Alba D'Alessandro, Simona Paladino, et al.
Molecular Pharmacology
|
September 20, 2008
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase
Iolanda Esposito, Maria Chiara Proto, Patrizia Gazzerro, et al.
Frontiers in Oncology
|
January 30, 2020
N<sup>6</sup>-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression
Giovanna Navarra, Cristina Pagano, Roberto Pacelli, et al.
Genes & Nutrition
|
March 26, 2011
Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells
Maria Notarnicola, Simona Pisanti, Valeria Tutino, et al.
International Journal of Cancer
|
November 5, 2016
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor
Elena Ciaglia, Mario Abate, Chiara Laezza, et al.
International Journal of Molecular Sciences
|
April 16, 2020
Multifaceted Role of PRDM Proteins in Human Cancer
Amelia Casamassimi, Monica Rienzo, Erika Di Zazzo, et al.
International Journal of Molecular Sciences
|
March 11, 2023
Impacts of Environmental Pollution on Brain Tumorigenesis
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
FEBS Open Bio
|
March 22, 2024
N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity
Cristina Pagano, Laura Coppola, Giovanna Navarra, et al.
Page
of 21